US Dollar vs Indonesian Rupiah holds steady as MSCI removes Indonesian stocks from indices

Traders Union
All News
Financial News
US Dollar vs Rupiah up 0.57% today

Highlights

Large-scale foreign capital outflows, totaling Rp 51.42 trillion year-to-date, have accelerated pressure on the Indonesian rupiah amid index-driven fund selling.
Imminent index rebalancing by FTSE Russell and MSCI in late May and June is forcing further passive fund withdrawals from Indonesian equities.
USD/IDR exhibits strong bullish momentum supported by multiple technical indicators, with a high probability of remaining within the Rp17,750–Rp17,950 range over the next week.

Rupiah pressured by index-driven outflows and waning investor confidence

Sustained foreign capital outflows from Indonesian financial markets have exerted steady pressure on the rupiah, as institutional investors reduce exposure in response to confirmed index rebalancing actions. The latest index adjustments by FTSE Russell and MSCI, set for late May and June, require passive funds to decrease holdings of Indonesian equities, prompting additional capital flight from the region. This large-scale withdrawal, with year-to-date outflows reaching Rp 51.42 trillion (approximately USD 2.9 billion), directly diminishes demand for the rupiah and intensifies the depreciation trend. While forced selling by funds is the primary driver, the broader weakening of currency confidence further supports the move in USD/IDR.

Overbought signals emerge as buyers dominate above technical floors

Price action in USD/IDR remains robust above key technical levels, with the spot rate positioned well clear of the MA-20 at Rp17,525.8, MA-50 at Rp17,288.8, and MA-200 at Rp16,909.8. The Ichimoku Kijun level on the D1 timeframe, at Rp17,518.6, now serves as immediate technical support. Momentum signals are notably strong — both MACD and ADX indicate an active buy mode, while oscillators highlight saturation: RSI stands at 73.1, CCI registers above 120, and Stoch RSI reads 55.6. Bull/Bear Power (BBP) remains strongly positive, reinforcing dominance by buyers, though the Awesome Oscillator is neutral and does not add trend confirmation. These combined readings suggest overbought conditions and a potential for short-term pauses despite ongoing strength.

Bullish risks remain high as overbought signals temper upside

Over the next five trading days, the most probable scenario places USD/IDR within a Rp17,750–Rp17,950 range, reflecting typical volatility and centering the forecast around current levels. The probability of a continued upward move remains above 80%, supported by persistent capital outflows and technical momentum. If the pair decisively clears resistance at Rp17,950, a bullish breakout could target higher levels; on the downside, a decline below Rp17,750 would signal a reversal and invalidate near-term support. Traders should monitor for signs of intraday exhaustion, as the overbought signal increases the odds of short-term pullbacks even as the overall bullish trend persists.

Anton Kharitonov, analyst at Traders Union, notes that persistent foreign capital outflows and forced index rebalancing are undermining rupiah demand. He sees strong technical momentum supporting the bullish move in USD/IDR, but signals of overbought conditions raise caution. The base case is a move within the Rp17,750–Rp17,950 range, with downside risk if support fails. "Until the pair drops below Rp17,750, I remain cautious and would avoid aggressive longs at these levels."

Earlier, analysts noted that persistent capital outflows and technical strength were propelling the bullish trend in USD/IDR. The current environment not only affirms that outlook but also highlights growing overbought risks, making the durability of the uptrend contingent on whether buyers can sustain momentum above Rp17,950 or if emerging exhaustion triggers a corrective pullback.

Source of Data: USD Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.